Authorised Therapeutic use (Phase IV) Chronic Tonsillitis

Comparison between Ropivacain and Lidocain for post-tonsillectomy pain

EU CTIS ID: 2025-520820-44-00

What this study is testing

Prove the superiority of ropivacain against lidocain regarding postoperative pain after tonsillectomy.

  • Therapeutic use (Phase IV)

A plain-language read of the study's public EU CTIS listing. The study team confirms the details.

Who can take part

You may be able to join if

  • Age: 18 years or older
  • Chronic Tonsillitis
  • Indication for tonsillectomy set by an otorhinolaryngologist

You likely can't join if

  • Intake of pain medication within 24h prior to the operation
  • chronic illnesses that make it impossible to take part in the trail because of contraindications to take the study medication
  • patients with peritonsillary absesses
  • patients with known allergies on any used medication within the protocols
  • patients who are unwilling or uncooperative
  • patients who have a postoperative bleeding that has to be treated with a secondary operation
See the full eligibility criteria
Who can join
  • Age: 18 years or older
  • Chronic Tonsillitis
  • Indication for tonsillectomy set by an otorhinolaryngologist
What rules you out
  • Intake of pain medication within 24h prior to the operation
  • chronic illnesses that make it impossible to take part in the trail because of contraindications to take the study medication
  • patients with peritonsillary absesses
  • patients with known allergies on any used medication within the protocols
  • patients who are unwilling or uncooperative
  • patients who have a postoperative bleeding that has to be treated with a secondary operation
  • patients with severe renal or hepatal dysfunction
  • Patients under 18 years of age
  • Patients who take medication, which is not allowed/interferes with the study outcome, or is contraindicated to take together with any study medication, and can not be paused for the trail duration
  • current pregnancy

The study team makes the final eligibility decision.

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.